These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7730327)
1. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. Wang F; Kan M; Yan G; Xu J; McKeehan WL J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327 [TBL] [Abstract][Full Text] [Related]
3. Ligand-specific structural domains in the fibroblast growth factor receptor. Wang F; Kan M; Xu J; Yan G; McKeehan WL J Biol Chem; 1995 Apr; 270(17):10222-30. PubMed ID: 7730326 [TBL] [Abstract][Full Text] [Related]
4. Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms. Hou J; Kan M; Wang F; Xu JM; Nakahara M; McBride G; McKeehan K; McKeehan WL J Biol Chem; 1992 Sep; 267(25):17804-8. PubMed ID: 1325450 [TBL] [Abstract][Full Text] [Related]
5. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894 [TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells. Feng S; Xu J; Wang F; Kan M; McKeehan WL Biochim Biophys Acta; 1996 Jan; 1310(1):67-73. PubMed ID: 9244177 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569 [TBL] [Abstract][Full Text] [Related]
8. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1. Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373 [TBL] [Abstract][Full Text] [Related]
9. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Shi E; Kan M; Xu J; Wang F; Hou J; McKeehan WL Mol Cell Biol; 1993 Jul; 13(7):3907-18. PubMed ID: 8321198 [TBL] [Abstract][Full Text] [Related]
10. Ligand binding properties of binary complexes of heparin and immunoglobulin-like modules of FGF receptor 2. Uematsu F; Kan M; Wang F; Jang JH; Luo Y; McKeehan WL Biochem Biophys Res Commun; 2000 Jun; 272(3):830-6. PubMed ID: 10860838 [TBL] [Abstract][Full Text] [Related]
11. The glycine box: a determinant of specificity for fibroblast growth factor. Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417 [TBL] [Abstract][Full Text] [Related]
12. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751 [TBL] [Abstract][Full Text] [Related]
13. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2. Scotet E; Houssaint E Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315 [TBL] [Abstract][Full Text] [Related]
14. Engineering of fibroblast growth factor: alteration of receptor binding specificity. Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030 [TBL] [Abstract][Full Text] [Related]
15. Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. Xu J; Nakahara M; Crabb JW; Shi E; Matuo Y; Fraser M; Kan M; Hou J; McKeehan WL J Biol Chem; 1992 Sep; 267(25):17792-803. PubMed ID: 1325449 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate. Lu W; Luo Y; Kan M; McKeehan WL J Biol Chem; 1999 Apr; 274(18):12827-34. PubMed ID: 10212269 [TBL] [Abstract][Full Text] [Related]
17. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7. Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710 [TBL] [Abstract][Full Text] [Related]
19. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Yan G; Fukabori Y; McBride G; Nikolaropolous S; McKeehan WL Mol Cell Biol; 1993 Aug; 13(8):4513-22. PubMed ID: 7687739 [TBL] [Abstract][Full Text] [Related]
20. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2. Lopez ME; Korc M J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]